Portal de Periódicos da CAPES

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

2010; Elsevier BV; Volume: 21; Linguagem: Inglês

10.1093/annonc/mdq273

1569-8041

Eric Van Cutsem, M. Dicato, Nadir Arber, Jordan Berlin, Andrés Cervantes, Fortunato Ciardiello, Aimery de Gramont, Eduardo Díaz‐Rubio, Michel Ducreux, Ravit Geva, Bengt Glimelius, R. Glynne Jones, Axel Grothey, Thomas Gruenberger, Daniel G. Haller, Karin Haustermans, Roberto Labianca, Heinz‐Josef Lenz, Bruce D. Minsky, Bernard Nordlinger, Atsushi Ohtsu, Nikolaos Pavlidis, P. Rougier, Wolff Schmiegel, CJH van de Velde, Hans‐Joachim Schmoll, Alberto Sobrero, Josep Tabernero,

Gastric Cancer Management and Outcomes

The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC.